Evaluation of Repeated Injectable PRF Following SRP in Patients With Periodontitis
Evaluation of the Clinical and Biochemical Efficacy of Repeated Injectable Platelet-Rich Fibrin Application Following Scaling and Root Planing in Patients With Periodontitis
1 other identifier
interventional
20
1 country
1
Brief Summary
The goal of this clinical trial is to learn if a treatment called injectable platelet-rich fibrin (i-PRF) helps improve gum health in people with a type of gum disease called Stage 3 Grade B periodontitis. The main questions this study aims to answer are: Does i-PRF help reduce gum inflammation and support healing? Are there changes in certain biological markers after using i-PRF? Researchers will compare two sides of the mouth. One side will receive i-PRF, and the other will be treated with salt water (saline) as a comparison. Participants will: Have a dental cleaning called scaling and root planing (SRP) Get i-PRF injected into deep gum pockets on one side of the mouth Have salt water placed in the other side's gum pockets Give gum fluid samples and have gum measurements taken at several visits (including 3 months later) Provide a small blood sample to prepare the i-PRF Researchers will collect and study gum fluid and look at markers related to healing and inflammation. The study will help find out if i-PRF is useful as a new treatment option for gum disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2025
CompletedFirst Submitted
Initial submission to the registry
May 28, 2025
CompletedFirst Posted
Study publicly available on registry
June 19, 2025
CompletedDecember 31, 2025
October 1, 2023
1 year
May 28, 2025
December 26, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Changes in GCF levels of TGF-β and PDGF at multiple time points.
Biochemical markers will be analyzed at baseline, 2 weeks, 4 weeks, and 3 months. The biochemical data will be correlated with clinical periodontal parameters to assess the relationship between molecular changes and clinical outcomes, thereby providing a comprehensive evaluation of treatment efficacy.
From baseline to third month
Changes in clinical periodontal parameters, including Probing Pocket Depth and Clinical Attachment Level, will be evaluated at baseline and at the third month.
Clinical data will be evaluated at baseline and at the third month.
From baseline to third month
Secondary Outcomes (2)
Changes in GCF levels of PF 4 and MPO at multiple time points.
From baseline to third month
Changes in clinical periodontal parameters, including Plaque Index, Gingival Index, and Bleeding on Probing evaluated at baseline and at the third month.
From baseline to third month
Study Arms (2)
Test Site
EXPERIMENTALRepeated application of İ-PRF to periodontal pockets in the test sites.
Control Site
SHAM COMPARATORControl sites received a sham intervention consisting of sterile saline solution irrigation into the periodontal pockets, to mimic the procedural aspects of PRF placement without delivering any biologically active material.
Interventions
Repeated application of I-PRF to the periodontal pockets in the test sites was performed twice: once immediately following scaling and root planing (SRP), and once at the third week.
Control sites received a sham intervention consisting of sterile saline solution irrigation into the periodontal pockets, to mimic the procedural aspects of PRF placement without delivering any biologically active material.
Eligibility Criteria
You may qualify if:
- Being diagnosed with Stage 3 Grade B periodontitis
- Being between the ages of 18-65
You may not qualify if:
- Smoking
- Having a systemic disease
- Taking any medication
- Being pregnant or breastfeeding
- Having received chemotherapy, radiotherapy or immunosuppressant treatments
- Having received periodontal treatment in the last 6 months
- Having used antibiotics in the last 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saglik Bilimleri Universitesi Gulhane Dis Hekimligi Fakultesi
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- In addition to masking the participants, the researcher who performed the biochemical analyses was also masked.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2025
First Posted
June 19, 2025
Study Start
December 1, 2023
Primary Completion
December 1, 2024
Study Completion
May 1, 2025
Last Updated
December 31, 2025
Record last verified: 2023-10